Jamal Musiala Suffers Renewed Absence Seizure; Camp Cites Medication Adjustment
Jamal Musiala has suffered a renewed health setback involving absence seizures, as reported by ran on Sunday.
The incident occurred last Monday, marking the second such occurrence since the midfielder experienced two collapses during test matches in August.
According to ran, the player’s camp views these events as part of an ongoing medical process involving the adjustment of medication. While the most recent incident followed a change in dosage, the player’s side said that they reverted to the previous regimen and have reported no further issues. Musiala was able to complete all training sessions and returned to the pitch on Friday following a two-month absence due to a muscle injury, appearing in the 1-1 draw against 1. FC Köln.
Despite his return to play, senior figures at FC Bayern München have publicly questioned the long-term viability of his contract, which runs until 2030 and is worth approximately 25 million euros annually plus bonuses. Following the match against Köln, supervisory board member Karl-Heinz Rummenigge expressed skepticism about Musiala’s future performance levels. “If he does not become the old Jamal again, then we must talk, because then these sums are naturally, with all due respect, no longer representable,” Rummenigge told Sky.
The public scrutiny from club leadership, including Uli Hoeneß and CEO Jan-Christian Dreesen, has drawn criticism, according to ran.
During the club’s annual general meeting on Saturday, Dr. Jonatan Hoffmann, a neurologist and Bayern fan, addressed the leadership directly. “What from my point of view is not helpful is to publicly question whether he will ever reach his level again, as Mr. Dreesen, Mr. Hoeneß and yesterday, taken to the extreme, Mr. Rummenigge have done,” he said.
The international players’ union FIFPRO also issued a statement criticizing the club’s approach. The organization described the repeated public comments as a “coordinated strategy” intended to exert pressure on Musiala and his advisors ahead of potential negotiations. FIFPRO said that the club has a duty of care, noting that public debates regarding a player’s health and future can exacerbate stress during a recovery period.
Club president Herbert Hainer defended the leadership’s stance during the meeting, framing the comments as expressions of concern for both the player and the club. Addressing the timing of the diagnosis, Hainer and Dreesen both said that the club was unaware of the neurological issues when Musiala signed his contract in February 2025.
Dreesen maintained that the recent comments were not intended to apply pressure, telling those in attendance, “He needs the time to come back. That is what we have said multiple times. He must get that, and then we will see how it looks at the beginning of next year.”